UBS Group upgraded shares of CochLear (OTCMKTS:CHEOY - Free Report) from a hold rating to a strong-buy rating in a report released on Wednesday morning,Zacks.com reports.
CochLear Trading Up 0.5%
Shares of CHEOY traded up $0.45 during mid-day trading on Wednesday, reaching $92.83. The company's stock had a trading volume of 2,962 shares, compared to its average volume of 6,638. CochLear has a 52 week low of $74.76 and a 52 week high of $115.85. The company's fifty day moving average price is $87.10 and its two-hundred day moving average price is $88.69.
CochLear Company Profile
(
Get Free Report)
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Further Reading
Before you consider CochLear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CochLear wasn't on the list.
While CochLear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
